Showing 1041-1050 of 23044 results for "".
Type 2 Diabetes in Children and Adolescents
https://reachmd.com/programs/diabetes-discourse/type-2-diabetes-in-children-and-adolescents/5084/The emergence of type 2 diabetes in children and adolescents over the past 20 years represents a shift in pediatric chronic disease. Join host Dr. Steven Edelman and his guest, professor of pediatrics and director of the Children’s Diabetes and Endocrine Center of South Texas at Driscoll Children’sTherapeutic Monitoring of Vancomycin in Adult Patients
https://reachmd.com/programs/focus-on-pharmacy/therapeutic-monitoring-of-vancomycin-in-adult-patients/4584/Vancomycin has come full circle in recent years. First used as an alternative to penicillin nearly a half-century ago, it was surpassed by methicillin and other semisynthetic penicillins that were regarded as less toxic. Paradoxically, the subsequent rise of methicillin-resistant Staphylococcus aureAir Travel and Venous Thrombosis: What's the Risk?
https://reachmd.com/programs/clinicians-roundtable/air-travel-and-venous-thrombosis-whats-the-risk/2373/Dr. Suzanne Cannegieter, director of clinical epidemiology, and the lead international researcher for the Wright Project, from Leiden University Medical Center in the Netherlands, talks about the history of research on deep venous thrombosis and extensive air travel.Can The Obesity Problem be Attacked Like Tobacco?
https://reachmd.com/programs/clinicians-roundtable/can-the-obesity-problem-be-attacked-like-tobacco/2055/If we examine the number of deaths in this country attributable to behavioral causes, the #1 problem is tobacco smoking – killing over 400,000 people alone. Can you guess what is #2? Join the head of the Smoking Cessation Leadership Center, Dr. Steven Schroeder as he discusses with host Dr. LeslieCerebral Oximetry
https://reachmd.com/programs/clinicians-roundtable/cerebral-oximetry/1405/In this segment Dr. James Slater talks about a newer type of oxygen monitoring during surgical procedures called cerebral oximetry. Dr. Slater talks about how the oxygen levels in the brain are monitored and adjusted during surgery and how surgical outcomes can be improved with cerebral oximetry moMicrochimerism and Rheumatoid Arthritis
https://reachmd.com/programs/clinicians-roundtable/microchimerism-and-rheumatoid-arthritis/900/Rheumatoid Arthritis often improves during pregnancy. Why? Truth is stranger than fiction here as it appears that immunologically competent fetal cells leaking into the maternal circulation moderate the maternal immune response to "self."Device Reduces Risk of Brain Injury After Heart Valve Replacement
https://reachmd.com/programs/the-jama-report/device-reduces-risk-brain-injury-after-heart-valve-replacement/8331/A new study in JAMA found that the use of a cerebral protection device reduced the number and volume of brain lesions after heart valve replacement.The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
https://reachmd.com/programs/eye-on-ocular-health/the-evolution-of-retinal-vein-occlusion-treatment-from-laser-to-anti-vegf/37665/The treatment landscape for branch and central retinal vein occlusions has evolved significantly over the past few decades. From early reliance on laser therapy to the advent of anti-VEGF agents, clinicians now have more effective tools to ensure improved patient outcomes. Tune in to hear Dr. Lisa SInvestment: How a Physician Can Earn Less Than a Waiter
https://reachmd.com/programs/your-money-your-life-financial-advice-for-physicians/investment-how-physician-can-earn-less-waiter/8132/What can a doctor earn as an active investor? Probably way less than you think. Join Jim Hemphill, CERTIFIED FINANCIAL PLANNER™ and co-founder of TGS Financial Advisors, as he calculates how investment activity translates into compensation per hour. Click here to learn more about other financial relRisk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
https://reachmd.com/programs/eye-on-ocular-health/risk-of-rvo-in-type-2-diabetes-glp-1-receptor-agonists-versus-dpp-4-inhibitors/37663/Among patients with type 2 diabetes, retinal vein occlusion (RVO) is a significant clinical challenge, as well as a leading cause of irreversible vision loss. With vascular health at the center of diabetes management, the choice of glucose-lowering therapy may influence ocular outcomes. Join Dr. Mim